Free Trial

Universal Health Services (UHS) Stock Forecast & Price Target

$180.82
-0.66 (-0.36%)
(As of 07/19/2024 ET)

Universal Health Services - Analysts' Recommendations and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Based on 14 Wall Street analysts who have issued ratings for Universal Health Services in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 14 analysts, 1 has given a sell rating, 5 have given a hold rating, 7 have given a buy rating, and 1 has given a strong buy rating for UHS.

Consensus Price Target

$194.21
7.41% Upside
High Forecast$236.00
Average Forecast$194.21
Low Forecast$162.00

According to the 14 analysts' twelve-month price targets for Universal Health Services, the average price target is $194.21. The highest price target for UHS is $236.00, while the lowest price target for UHS is $162.00. The average price target represents a forecasted upside of 7.41% from the current price of $180.82.

TypeCurrent Forecast
7/22/23 to 7/21/24
1 Month Ago
6/22/23 to 6/21/24
3 Months Ago
4/23/23 to 4/22/24
1 Year Ago
7/22/22 to 7/22/23
Consensus Rating
Moderate Buy
Hold
Moderate Buy
Hold
Strong Buy
1 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
7 Buy rating(s)
6 Buy rating(s)
7 Buy rating(s)
5 Buy rating(s)
Hold
5 Hold rating(s)
7 Hold rating(s)
4 Hold rating(s)
8 Hold rating(s)
Sell
1 Sell rating(s)
1 Sell rating(s)
1 Sell rating(s)
1 Sell rating(s)
Consensus Price Target$194.21$190.43$179.71$148.93
Forecasted Upside7.41% Upside11.17% Upside10.47% Upside11.85% Upside
Get Universal Health Services Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for UHS and its competitors with MarketBeat's FREE daily newsletter.

UHS Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

UHS Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Universal Health Services Stock vs. The Competition

TypeUniversal Health ServicesMedical CompaniesS&P 500
Consensus Rating Score
2.57
2.72
2.51
Consensus RatingModerate BuyModerate BuyModerate Buy
Predicted Upside7.41% Upside3,241.50% Upside10.06% Upside
News Sentiment RatingPositive News
Positive News
Positive News
DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
7/10/2024Barclays
2 of 5 stars
 Boost TargetEqual Weight ➝ Equal Weight$189.00 ➝ $198.00+9.89%
7/9/2024Cantor Fitzgerald
3 of 5 stars
 Reiterated RatingUnderweight ➝ Underweight$162.00 ➝ $162.00-10.53%
6/26/2024Baird R W
0 of 5 stars
M. Ha
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeHold ➝ Strong-Buy
6/26/2024Robert W. Baird
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeNeutral ➝ Outperform$198.00 ➝ $236.00+25.73%
5/30/2024JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetNeutral ➝ Neutral$182.00 ➝ $186.00+0.38%
5/20/2024UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeNeutral ➝ Buy$189.00 ➝ $226.00+27.18%
5/7/2024Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetSector Perform ➝ Sector Perform$183.00 ➝ $189.00+11.08%
4/30/2024TD Cowen
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetHold ➝ Hold$181.00 ➝ $183.00+7.50%
4/25/2024Stephens
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingEqual Weight ➝ Equal Weight$185.00+13.21%
4/12/2024Deutsche Bank Aktiengesellschaft
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetBuy ➝ Buy$208.00 ➝ $203.00+21.98%
3/28/2024Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOverweight ➝ Overweight$195.00 ➝ $200.00+9.83%
3/6/2024Mizuho
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy ➝ Buy$175.00 ➝ $200.00+13.96%
3/4/2024The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy ➝ Buy$170.00 ➝ $189.00+9.02%
2/29/2024Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy ➝ Buy$170.00 ➝ $193.00+17.48%
7/27/2023Credit Suisse Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost Target$163.00 ➝ $169.00+19.49%
6/2/2023VNET Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingAssumes
6/2/2023Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeNeutral ➝ Buy$163.00+24.29%
5/26/2023SVB Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeMarket Perform ➝ Outperform$147.00 ➝ $170.00+32.83%
5/8/2023888
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingMaintains
3/1/2023Wolfe Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeOutperform ➝ Peer Perform
10/27/2022SVB Leerink
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetMarket Perform$98.00 ➝ $114.00+4.23%
8/9/2022Cowen
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower Target$119.00+8.32%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Sunday at 09:50 PM ET.

UHS Forecast - Frequently Asked Questions

What is Universal Health Services' forecast for 2024?

According to the research reports of 14 Wall Street equities research analysts, the average twelve-month stock price forecast for Universal Health Services is $194.21, with a high forecast of $236.00 and a low forecast of $162.00.

Should I buy or sell Universal Health Services stock right now?

14 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Universal Health Services in the last year. There is currently 1 sell rating, 5 hold ratings, 7 buy ratings and 1 strong buy rating for the stock. The consensus among Wall Street research analysts is that investors should "moderate buy" UHS shares.

Does Universal Health Services's stock price have much upside?

According to analysts, Universal Health Services's stock has a predicted upside of 11.66% based on their 12-month stock forecasts.

Has Universal Health Services been upgraded by Wall Street analysts recently?

Over the previous 90 days, Universal Health Services's stock had 4 upgrades by analysts.

What analysts cover Universal Health Services?

Universal Health Services has been rated by research analysts at Baird R W, Barclays, Cantor Fitzgerald, JPMorgan Chase & Co., Robert W. Baird, Royal Bank of Canada, Stephens, TD Cowen, and UBS Group in the past 90 days.

Do Wall Street analysts like Universal Health Services more than its competitors?

Analysts like Universal Health Services less than other "medical" companies. The consensus rating score for Universal Health Services is 2.57 while the average consensus rating score for "medical" companies is 2.72. Learn more on how UHS compares to other companies.


This page (NYSE:UHS) was last updated on 7/21/2024 by MarketBeat.com Staff

From Our Partners